Seroprevalence of Lyme Borreliosis in Europe: Results from a Systematic Literature Review (2005–2020)
Vector-Borne and Zoonotic Diseases · 2023-04 · 23 (4) · 195-220
DOI: 10.1089/vbz.2022.0069 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Vector-Borne and Zoonotic Diseases, online erschienen am 12.04.2023. Verfasst von Leah Burn und 9 weiteren Autor:innen. Beteiligte Einrichtung: P95 Pharmacovigilance & Epidemiology, Princeton, New Jersey, USA. Hauptthemen laut MEDLINE: Lyme Disease, Borrelia burgdorferi, Borrelia burgdorferi Group, Ticks. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lyme borreliosis (LB), a tick bite-transmitted infection caused by Borrelia burgdorferi sensu lato ( Bbsl ) complex spirochetes, is the most common tickborne disease in Europe. Studies in European countries have reported LB seroprevalence (prevalence of antibodies to Bbsl infection) and diagnostic strategies used for testing. We conducted a systematic literature review to summarize contemporary LB seroprevalence in Europe.
Methods
PubMed, Embase, and CABI Direct (Global Health) databases were searched from 2005 to 2020 to identify studies reporting LB seroprevalence in European countries. Reported single-tier and two-tier test results were summarized; algorithms (standard or modified) were used to interpret final test results from studies that used two-tier testing.
Results
The search yielded 61 articles from 22 European countries. Studies used a range of diagnostic testing methods and strategies (48% single-tier, 46% standard two-tier, and 6% modified two-tier). In 39 population-based studies, of which 14 were nationally representative, seroprevalence estimates ranged from 2.7% (Norway) to 20% (Finland). There was substantial heterogeneity among studies in terms of design, cohort types, periods sampled, sample sizes, and diagnostics, which limited cross-study comparisons. Nevertheless, among studies that reported seroprevalence in persons with greater exposure to ticks, LB seroprevalence was higher among these groups than in the general population (40.6% vs. 3.9%). Furthermore, among studies that used two-tier testing, general population LB seroprevalence was higher in Western Europe (13.6%) and Eastern Europe (11.1%) than in Northern Europe (4.2%) and Southern Europe (3.9%).
Conclusion
Despite variations in LB seroprevalence between and within European subregions and countries, high seroprevalence was observed in certain geographic regions and particular risk groups, suggesting significant disease burden and supporting the need for improved, targeted public health interventions such as vaccination. Harmonized approaches to serologic testing and more nationally representative seroprevalence studies are needed to better understand the prevalence of Bbsl infection in Europe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- P95 Pharmacovigilance & Epidemiology, Princeton, New Jersey, USA.
- Pfizer Global Medical Affairs, Vaccines, Vienna, Austria.
- Pfizer Vaccines Medical, Walton Oaks, United Kingdom.
- P95 Pharmacovigilance & Epidemiology, Leuven, Belgium.
- Pfizer Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA.
- Pfizer Emerging Markets Medical Affairs, Vaccines, Paris, France.
Zitieren
APA
Burn, L., Pilz, A., Vyse, A., Gutiérrez Rabá, A. V., Angulo, F. J., Tran, T. M. P., Fletcher, M. A., Gessner, B. D., Moïsi, J. C., & Stark, J. H. (2023). Seroprevalence of Lyme Borreliosis in Europe: Results from a Systematic Literature Review (2005–2020). Vector-Borne and Zoonotic Diseases, 23(4), 195-220. https://doi.org/10.1089/vbz.2022.0069
Vancouver
Burn L, Pilz A, Vyse A, Gutiérrez Rabá AV, Angulo FJ, Tran TMP, et al. Seroprevalence of Lyme Borreliosis in Europe: Results from a Systematic Literature Review (2005–2020). Vector-Borne and Zoonotic Diseases. 2023;23(4):195-220. doi:10.1089/vbz.2022.0069
BibTeX
@article{Burn2023,
author = {Burn, Leah and Pilz, Andreas and Vyse, Andrew and Gutiérrez Rabá, Aura Victoria and Angulo, Frederick J and Tran, Thao Mai Phuong and Fletcher, Mark A and Gessner, Bradford D and Moïsi, Jennifer C and Stark, James H},
title = {Seroprevalence of Lyme Borreliosis in Europe: Results from a Systematic Literature Review (2005–2020)},
journal = {Vector-Borne and Zoonotic Diseases},
year = {2023},
volume = {23},
number = {4},
pages = {195--220},
doi = {10.1089/vbz.2022.0069}
}
EUVIMED